Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02507219 · ClinicalTrials.gov registry record · Phase 2
Study of Ibuprofen Effects on Brain Function
A Phase 2 study, sponsored by Laureate Institute for Brain Research.
- Completed
- Registry status
- Phase 2
- Development phase
- 24
- Enrollment target
NCT02507219 is a Phase 2 study that has completed, run by Laureate Institute for Brain Research. The registered enrollment target is 24 participants.
The verdict
NCT02507219, a Phase 2 study, has completed, sponsored by Laureate Institute for Brain Research.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 24 participants
- Enrollment target
Study Summary
The aim of this project is to determine whether the acute oral administration of Ibuprofen changes the activation pattern in the amygdala and other brain structures during functional magnetic resonance imaging. The investigators use a double-blind, randomized, repeated-measures design. Each of the 20 healthy control subjects will be tested three times and receive placebo, 200 mg or 600 mg dose of ibuprofen p.o. The study will consist of 4 sessions: a baseline screening session and 3 testing sessions scheduled 1-2 weeks apart. Each of these individuals will undergo a multi-level assessment based on the RDoC approach that consists of (a) a standardized diagnostic assessment, (b) self-report questionnaires assessing the positive and negative valence domains as well as interoception, (c) behavioral tasks assessing reward-related processing, avoidance, and aversive processing, cognition, and interoception; (d) physiological measurements consisting of facial emotion expression monitoring, heart rate and respiration, (e) functional magnetic resonance imaging focusing on reward-related processing, fear conditioning and extinction, cognitive inhibition, and interoceptive processing, and (f) biomarker assessments.
Interventions
- DRUG Ibuprofen
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2015-07 |
| Est. Completion | 2015-10 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02507219
The ClinicalTrials.gov registry entry for NCT02507219 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Laureate Institute for Brain Research, which has 45 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Ibuprofen is the first listed.
NCT02507219 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02507219 about?
NCT02507219 is a clinical study titled "Study of Ibuprofen Effects on Brain Function". The aim of this project is to determine whether the acute oral administration of Ibuprofen changes the activation pattern in the amygdala and other brain structures during functional magnetic resonance imaging. The investigators use a double-blind, randomized, repeated-measures design. Each of the 2...
What is the current status of trial NCT02507219?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 24 participants. The study started on 2015-07. Estimated completion is 2015-10.
What interventions are being tested in trial NCT02507219?
The interventions under investigation include: Ibuprofen (DRUG).
Who is sponsoring clinical trial NCT02507219?
This trial is sponsored by Laureate Institute for Brain Research, which has 45 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.